Log in to save to my catalogue

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7602186

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

About this item

Full title

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

Publisher

Basel: MDPI AG

Journal title

Cancers, 2020-10, Vol.12 (10), p.2973

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Glioblastoma (GBM) is the most fatal primary brain cancer in adults. Despite extensive treatment, tumors inevitably recur, leading to an average survival time shorter than 1.5 years. The 18 kDa translocator protein (TSPO) is abundantly expressed throughout the body including the central nervous system. The expression of TSPO increases in states of...

Alternative Titles

Full title

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7602186

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7602186

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers12102973

How to access this item